John Allport is the Vice President, Legal Affairs and Licensing with IntelliPharmaCeutics. He has been associated with the Company as its intellectual property attorney since its inception, and prior to that as counsel to its principals during their time at Biovail Corporation.

Intellectual property (IP) is a principal asset of IntelliPharmaCeutics. It includes drug delivery technology inventions, patents, trademarks, copyrights, trade secrets and know-how.

In his capacity as Director of Technology Licensing, Mr. Allport has responsibility to oversee the creation, protection, assertion and exploitation of the intellectual property assets of the Company for its maximum benefit, consistent with the Company's stated Objectives.

Mr. Allport has in excess of twenty years' experience in the field of intellectual property law. As an attorney with the internationally recognized IP firm Messrs. Sim, Hughes, Ashton & McKay of Toronto, he acted on behalf of the intellectual property litigation interests of such clients as Procter & Gamble, Warner Lambert, Corning Glass Works, Westinghouse Corporation, Teledyne, Raytheon, Hughes Aircraft, Monsanto Corporation, G.D. Searle and Swiss Army Brands, and against those of such companies as Bristol Myers, Bayer, 3M Corporation, Kimberly Clarke, Blockbuster/Viacom, and Sumitomo Electric.

He has also been engaged to assist in the creation and exploitation of the extensive IP licensing interests of such international licensing giants as Walt Disney Corporation, the Canadian Olympic Association and the World Wildlife Fund.